@ Board of Directors | SEBIO

SEBIO 2017 Board of Directors

Officers:
Chair: Todd Sherer, PhD, Emory University, Office of Technology Transfer
Vice-Chair and Secretary: Tina McKeon, Kilpatrick Townsend & Stockton, LLP
Treasurer: Mark Baxter, Ernst & Young
Ex Officio: Sue Washer, AGTC

Executive Committee:
Mark Baxter, Ernst & Young
Tom Callaway, MD, HealthQuest Capital
Becky Kaufman, King & Spalding LLP
Tina McKeon, Kilpatrick Townsend & Stockton, LLP
Doug Reed, Hatteras Venture Partners
Todd Sherer, PhD, Emory University, Office of Technology Transfer
Sue Washer, AGTC

Directors:
Brian Adams, PhD, Arbor Pharmaceuticals, Inc.
Russell Allen, Georgia Bio
William Brooke, Harbert Ventures Partners
Gerry Brunk, Lumira Capital
Nancy Bryan, BioFlorida
Jill Carroll, SR One
Joe Cook, III, Mountain Group Partners
David Day, Southeast BIO
Greg Duncan, Celtaxsys, Inc.
Tom Fagley, Hughes Pittman & Gupton, LLP
Jeff Gallagher, Virginia Biotechnology Association
Steve Hall, Lilly Ventures
H. Lee Herron, DVM, Georgia Research Alliance
Frank Hunt, PNP Therapeutics, Inc.
Garheng Kong, HealthQuest Capital
Andrew Krouse, Cavion, LLC
Sharon Krueger, University of Virginia, Office of the VP for Research
Scott McCarty, Silicon Valley Bank
Bibhash Mukhopadhyay, PhD, New Enterprise Associates
Kathy Nugent, PhD, BioAlabama
Jim O’Connell, University of Miami, Office of Technology Transfer
Dan O’Korn, Hutchison Law Group, PLLC
David Pierson, Syngenta Crop Protection
Robin Rasor, Duke University, Office of Technology Transfer
Larry Robbins, Wyrick Robbins Yates & Ponton, LLP
James Rosen
David Stern, Contego Medical
Ken Tindall, PhD, North Carolina Biotechnology Center
Evan Travis, Square 1 Bank
Abby Trotter, Life Science Tennessee
Geeta Vemuri, Baxalta
Miriam Wilson, Council for Entrepreneurial Development (CED)
David Winwood, PhD, Pennington Biomedical Research Center
Ford Worthy, Pappas Ventures
Karen Zederej, AxoGen, Inc.